Study for Endovascular Repair of Abdominal Aortic Aneurysms

What we are studying

The purpose of this study is to collect long-term patient results for a device that has recently been approved for use by the Food and Drug Administration (FDA) in the U.S. The device is used to treat a bulge or aneurysm of the aortic or aorto-iliac arteries without open surgery.

Who we are studying

  • Men and Women
  • Races:
    • White
    • African American
    • Asian
    • American Indian or Alaska Native
    • Native Hawaiian or Pacific Islander
    • Other
  • All Ethnicities
  • Ages 18+

Eligibility Criteria

  • Aortic or aortoiliac aneurysm with a diameter > 5 cm or with a history of growth > 0.5 cm per year
  • Or clinical indication for AAA repair
  • Non leaking/ruptured or symptomatic aneurysm
  • >18 years of age
  • Non pregnant or breastfeeding women
  • Normal kidney function

What is involved

  • As part of your institution’s standard of care you will be asked to have regularly scheduled follow-up visits with your doctor
  • For the purposes of this study information from these follow-up visits will be collected for up to 5 years
  • Depending on your institution’s standard of care these visits may be scheduled to take place before hospital discharge; approximately 30 days; 6 months; 12 months and annually thereafter after an endovascular graft has been placed
  • During the follow-up visits with your doctor you may have a CT scan (a special X-ray) of your abdomen
  • An additional abdominal X-ray
  • An ultrasound image of your kidneys
  • Blood tests
  • And a physical examination in accordance with standard of care.



Contact Information

Study Coordinator
Rob Paris, RN, CCRP
Principal Investigator
Justin Hurie, M.D.

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.